PAA 2.56% 20.0¢ pharmaust limited

Ann: MND Biomarkers and Pharmacodynamics Results, page-61

  1. 8,845 Posts.
    lightbulb Created with Sketch. 1712
    One would think that this must draw attention by itself, great news for mnd suffers, first treatment of its kind for MND and little to no adverse affects.
    I thank all participants in the trial and also thank those who have and continue to carry out the trial.
    A possible treatment I guess I should say, and developed by a small Australian company.
    Come on big pharmas this had great potential not only for mnd but human cancer.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.005(2.56%)
Mkt cap ! $97.22M
Open High Low Value Volume
19.5¢ 20.0¢ 19.5¢ $199.9K 1.004M

Buyers (Bids)

No. Vol. Price($)
8 457971 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 1207 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.